Dr. Hassan Al Hail

Dr. Hassan Al Hail Head of Epilepsy Services, Hamad Medical Corporation

UpToDate Review Epilepsy is one of the most common chronic neurologic disorders, and approximately 20 to 30 percent of patients with epilepsy will have medically and socially disabling seizure disorders. Such patients are at increased risk for serious morbidity and mortality, including cognitive disorders, depression, physical trauma, and sudden death in epilepsy. The goals of treatment for individuals with drug-resistant epilepsy are to render the patient seizure free, avoid treatment-related adverse effects, and allow the individual to become a participating and productive member of society. Most individuals who will respond favorably to antiseizure medications are successfully managed within the first two years of treatment. Patients who do not respond favorably to two antiseizure medications used appropriately are likely to have drug-resistant epilepsy and should be investigated for surgery and other alternative forms of treatment. Surgical therapy is an important and underutilized treatment in patients with drug-resistant focal epilepsy. Surgical procedures for epilepsy range from focal resection of the epileptogenic cortex (antero-mesial temporal lobe and other focal cortical resections) to interventions that remove or isolate the cortex of a grossly diseased hemisphere (functional hemispherectomy, anterior corpus callosotomy, multiple subpial transections). The latter procedures are most often performed in children and are not discussed further here. In general, only complete resection of the epileptogenic brain region offers the chance of long-term seizure freedom. This topic will discuss the surgical treatment of drug-resistant focal epilepsy in adults utilizing focal cortical resection. Epilepsy surgery in children and other aspects of epilepsy management and treatment in adults are discussed separately. (See "Overview of the management of epilepsy in adults" and "Evaluation and management of drug-resistant epilepsy" and "Seizures and epilepsy in children: Refractory seizures", section on 'Epilepsy surgery'.)

Specialty and Interest

Locations

Doha
Qatar

Experience

Senior Consultant
Hamad Medical Corporation-Hamad General Hospital
Doha

Head Of Department (HOD)
Epilepsy Services at HMC
Doha

Education and Training

American Academy of Neurology
Fellowship
FAAN
How can I make an appointment with Dr. Hassan Al Hail?
You can view Dr. Hassan Al Hail's profile on MedSynapse to make an appointment.
What is Dr. Hassan Al Hail's top areas of care?
Dr. Hassan Al Hail's top areas of care are Acute spinal cord injury, alzheimer's disease, amyotrophic lateral sclerosis (ALS), ataxia, Bbell's palsy, brain tumors, cerebral aneurysm, epilepsy, seizures, traumatic brain injury .
Who is Dr. Hassan Al Hail?
Dr. Hassan Al Hail is Neurologist in Doha. Dr. Hassan Al Hail is affiliated with medical facilities such as Hamad Medical Corporation-Hamad General Hospital and Epilepsy Services at HMC. Dr. Hassan Al Hail graduated from American Academy of Neurology.
What is Dr. Hassan Al Hail's education qualification?
Dr. Hassan Al Hail graduated from American Academy of Neurology.
Where does Dr. Hassan Al Hail work?
Dr. Hassan Al Hail is affiliated with medical facilities such as Hamad Medical Corporation-Hamad General Hospital and Epilepsy Services at HMC.
Why do patients visit Dr. Hassan Al Hail?
Patients frequently visit Dr. Hassan Al Hail for Acute spinal cord injury, alzheimer's disease, amyotrophic lateral sclerosis (ALS), ataxia, Bbell's palsy, brain tumors, cerebral aneurysm, epilepsy, seizures, traumatic brain injury .